FeesSafety
Pluang+
Home/Explore/US Market Price/Stocks/VTRS
icon
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Viatris Inc (VTRS) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Viatris (VTRS) trades at $18.48, up 0.16% with a bullish technical signal from moving averages. The company shows strong operational cash flow of $2.32B in 2025 and has beaten earnings estimates for three consecutive quarters. Recent positive developments include FDA approval for WAKIX in Japan and recognition as a top employer. However, fundamental challenges persist with negative net income margins (-2.79%) and elevated P/E ratio of 236.2, though revenue stability around $14.3B provides a foundation for recovery.
The investment case balances strong cash generation and dividend payments against profitability challenges. Analyst consensus targets $22.17 (20% upside) with 38% buy ratings, but investors face risks from debt levels ($14.04B long-term) and margin pressure. The stock offers value through consistent cash flow and strategic approvals, though turnaround execution remains critical for sustained re-rating.
Read full analysis

Key Stats

  • Market Cap
    $21.22B
  • Volume
    5,435,547
  • Sector
    Health
  • 52W High
    $18.66
  • 52W Low
    $10.11
  • Typical Hold Time
    57 Days
  • Enterprise Value
    $33.34B
  • Div Yield
    2.6%
  • Trading Activity
    -
$18
52W Low: $10.11
06 Nov 2025
52W High: $18.66
16 Oct 2026

Track Viatris Inc (VTRS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Viatris Inc has traded between a low of $10.11 and a high of $18.66, highlighting its annual price range. Buy and sell Viatris Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Viatris Inc

Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).

Most Recent News

Content is generated by Aura AI

PIMCO Access Income Fund faces volatility amid rising Treasury yields, yields 13.85% with strong distribution coverage.

PIMCO Access Income Fund (PAXS) is experiencing increased volatility due to rising Treasury yields and persistent inflation. The fund currently offers a 13.85% yield at a 7.4% discount to its net asset value (NAV) and maintains strong distribution co...

Market News
4 hours ago
Seeking Alpha
Neutral
PIMCO Access Income Fund faces volatility amid rising Treasury yields, yields 13.85% with strong distribution coverage.

Remittix raises $33M, burns 300M RTX tokens, as XRP Ledger update sparks $10 XRP price talk

Remittix has raised $33 million and will burn 300 million RTX tokens, reducing supply by 20% ahead of public trading starting November 24, 2026. This token burn and near-cap funding boost scarcity and investor interest. Meanwhile, the XRP Ledger's No...

Market News
5 hours ago
Not Specified
Bullish
news icon
Remittix raises $33M, burns 300M RTX tokens, as XRP Ledger update sparks $10 XRP price talk

XTransfer debuts at Money20/20 USA to boost cross-border B2B payments in Latin America.

XTransfer, a leading global B2B cross-border payment platform, made its first appearance at Money20/20 USA 2026 in Las Vegas to accelerate its expansion into Latin American markets. The company recently completed regulatory registration in Chile, ena...

Market News
5 hours ago
Na
Bullish
news icon
XTransfer debuts at Money20/20 USA to boost cross-border B2B payments in Latin America.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $21.22B
  • Volume
    5,435,547
  • Sector
    Health
  • 52W High
    $18.66
  • 52W Low
    $10.11
  • Typical Hold Time
    57 Days
  • Enterprise Value
    $33.34B
  • Div Yield
    2.6%
  • Trading Activity
    -
$18
52W Low: $10.11
06 Nov 2025
52W High: $18.66
16 Oct 2026

Track Viatris Inc (VTRS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Viatris Inc has traded between a low of $10.11 and a high of $18.66, highlighting its annual price range. Buy and sell Viatris Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!